NFA-014

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNFA-014
Drug Alias NameNFA-014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidoglycan modulatorsCell wall inhibitors
TargetsPeptidoglycan
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesIntron Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesIntron Biotechnology
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A